Blog

Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel

oncbrothers.com

Oct 21, 2024, 13:21

Rahul Gosain: US FDA approval of Durvalumab for resectable NSCLC with Mara Antonoff and Sandip Patel

”Lung Cancer: We speak about the US FDA approval of Durvalumab based off AEGEAN (and options in perioperative/postoperative) for resectable Non-Small Cell Lung Cancer with Mara Antonoff and Sandip Patel.

Full Discussion:

Link 1.
Link 2.
Also on ‘Oncology Brothers’ podcast.”

View attached video.

Drs. Rohit Gosain and Rahul Gosain (aka Oncology Brothers), are medical oncologists/hematologists. Through their social media platforms like X/Twitter, they actively engage with their audience. With their own YouTube channel and podcast, they provide accessible resources for cancer patients and their families. Additionally, their participation in live conferences ensures that cancer patients receive the best care closer to home, reflecting their commitment to advancing oncology and improving patient outcomes through education and outreach.

AEGEAN cancer Durvalumab Lung cancer Mara Antonoff non small cell lung cancer OncoDaily Oncology Rahul Gosain Sandip Patel US FDA Oncology Drugs Advisory Committee

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success